Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 19, 2025 08:54 ET | Source: Sixty Degrees Pharmaceuticals

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

60 Degrees Pharma selects Mount Sinai as central site for Phase II tafenoquine trial in chronic babesiosis; enrollment starts Q4 2025, data 2026.
May 24, 2022 19:23 ET | Source: Rensselaer Polytechnic Institute

Rensselaer Polytechnic Institute and Icahn School of Medicine at Mount Sinai Announce Joint Center for Engineering and Precision Medicine in New York City

NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) -- Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai recently announced the creation of the Center for Engineering and...
September 09, 2020 09:00 ET | Source: LymeMIND

LymeMIND, a division of the Icahn School of Medicine at Mount Sinai, to Host LymeMIND 2020 Virtual Conference on October 10

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- LymeMIND, the data coordination center of the Cohen Lyme & Tickborne Disease Initiative, housed at the Icahn School of Medicine at Mount Sinai, today...
May 18, 2019 17:45 ET | Source: National Lipid Association

Mount Sinai Icahn School of Medicine’s Dr. Robert S. Rosenson Receives Foundation of the National Lipid Association 2019 Clinician/Educator Award

MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- Robert S. Rosenson, MD, FACC, FACP, FAHA, FESC, FNLA, FACCP, Professor of Medicine and Director of Cardiometabolic Disorders at the Icahn School of Medicine...
April 05, 2019 08:02 ET | Source: Cognition Therapeutics, Inc.

Cognition Therapeutics Expands Clinical Expertise on Medical Advisory Board with Addition of Drs. Mary Sano and Philip Scheltens

Pittsburgh, April 05, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative...
April 24, 2017 10:42 ET | Source: American Health Council

American Health Council Names Matilde Inglese, MD, Ph.D. to Education Board

NEW YORK, April 24, 2017 (GLOBE NEWSWIRE) -- Dr. Matilde Inglese, Associate Professor of Neurology, Radiology and Neuroscience at the Icahn School of Medicine at Mount Sinai has been selected to...
November 18, 2013 18:14 ET | Source: Mesoblast

Mesoblast's Cell Therapy Strengthens Native Heart Function In Patients With End-Stage Heart Failure on Assisted Circulatory Support

NEW YORK and MELBOURNE, Australia, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Patients with end-stage or New York Heart Association (NYHA) class IV heart failure who receive a surgically implanted left...